UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1-U
CURRENT REPORT PURSUANT TO REGULATION A
Date of Report (Date of earliest event reported): May 8, 2017
MED-X, INC. |
(Exact name of registrant as specified in its charter) |
Nevada | 46-5473113 | |
(State of other jurisdiction of | (I.R.S. Employer |
8236 Remmet Avenue, Canoga Park, California 91304
(Full mailing address of principal executive offices)
(818) 349-2870
(Issuer’s telephone number, including area code)
Title of each class of securities issued pursuant to Regulation A:
Common Stock, par value $0.001 per share
Item 9. Other Events
Lifting of Temporary Suspension Order. An Administrative Law Judge with the Securities and Exchange Commission (the “Commission”) ruled in favor of Med-X, Inc. (the “Company”) on May 8, 2017, ruling that the Commission’s Order Temporarily Suspending Exemption of the Company’s Regulation A+ Offering be vacated, thereby restoring the availability to the Company of the Regulation A+ exemption from registration under the Securities Act of 1933, as amended. The Commission has the right to appeal the ruling. The Company plans to file a Post-Qualification Amendment to its Offering Statement previously declared qualified by the Commission on January 29, 2016 to update it and resume its offering of Common Stock under Regulation A+. The timing of the resumption of the offering is not yet known as it depends on the duration of the Commission’s review of the planned filing.
This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors.
| 2 |
SIGNATURES
Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MED-X, INC.
(Exact name of issuer as specified in its charter) | |||
Date: May 8, 2017 | By: | /s/ Matthew Mills | |
|
| Matthew Mills | |
| President | |||
3 |
